Jim Miller is the founder of Split Infinity LLC.  He was previously a Manager with PwC’s Pharmaceutical and Life Sciences R&D Advisory Services practice.  He has worked across Europe and North America for the past 7 years specializing in R&D Operations.  Jim has over 10 years of biomedical research experience having worked in both academic institutions and in the defense industry. His areas of scientific expertise are immunology, molecular biology, and biological defense.

Prior to joining PwC, Jim was a researcher within the Neuroimmunology and Inflammation Program at Rockefeller University (RU), where he did his post-doctoral research and held the position of Adjunct Faculty Member.  Jim has been trained to conduct human clinical trials and has completed the Center for Clinical and Translational Science Certificate Program at RU.

Additionally, Jim has also been a researcher at the Weill Medical College of Cornell University and at Advanced Biosystems (ABS). At ABS he worked with former Soviet biological weapons specialists on anthrax and was a project lead in the development of the Biodefense Ph.D. program for George Mason University.